Presentation is loading. Please wait.

Presentation is loading. Please wait.

Practical aspects Of SLIT

Similar presentations


Presentation on theme: "Practical aspects Of SLIT"— Presentation transcript:

1 Practical aspects Of SLIT
Giovanni Passalacqua Allergy & Respiratory Diseases Dept.Internal Medicine- University of Genoa ITALY

2 SLIT Trials in Guidelines
1998 2001 2007 2008 2009 WHO Pos pap EAACI Pos Pap ARIA 1st version Galen Update ARIA 2nd version WAO Pos pap TODAY 4 5 8 22 35 60 66

3 WHO Pos Pap. Therapeutical vaccines for allergic diseases
Allergy 1998 Standards for practical allergen-specific immunotherapy. Allergy 2006 Allergen immunotherapy: A practice parameter second update JACI 2007

4 Passalacqua G Allergy Immunol Clin North Am 2011

5 Meta-analysis of the efficacy of sublingual immunotherapy in allergic asthma in pediatric patients, 3 to 18 years of age. M Penagos, G Passalacqua, E Compalati, C Baena-Cagnani, S Orozco, A Pedroza GW Canonica

6 Allergy 2011

7 Symptom Score Rhintis

8 JACI 2010

9 HOW DO WE MANAGE SLIT HOW DO PATIENTS MANAGE SLIT ?

10 RHINITIS HIGH RISK? ASTHMA
Indications Moderate- severe persistent Not cost- effective? Mild persistent RHINITIS Moderate- severe intermitt. Mild intermitt. IMMUNOTHERAPY. HIGH RISK? ASTHMA Intermitt. Mild Moderate Severe

11 FACTORS TO BE CONSIDERED IN PRESCRIBING IMMUNOTHERAPY
IgE-mediated mechanism Confirmed aetiological role of the allergen Duration of symptoms Response to drug therapy Expected effectiveness Availability of standardized vaccines Contraindications and risks Costs Compliance WHO Pos Pap 1998

12 CAUSAL ROLE OF THE ALLERGEN(S):
Clinical history and exposure SKIN TESTING RAST ASSAY NASAL (CONJUNCTIVAL) CHALLENGE SLIT (IT in general) for the clinically relevant allergen(s) Preferably one, but in selected cases 2 or 3 extracts.

13 Subcutaneous (SCIT) Sublingual (SLIT) ADMINISTRATION Standard Rush Ultra-rush Cluster No build-up (SLIT) BUILD-UP Monthly (SCIT) Once a day (SLIT) Each other day (SLIT) Once a week TIMING Preseasonal Pre-coseasonal Co-seasonal Continuous REGIMEN

14 SLIT NO BUILD UP 7/60 MAINTENANCE DAILY 31/60 MAINTENANCE 3/wk 20/60
NO BUILD UP 7/60 MAINTENANCE DAILY 31/60 MAINTENANCE 3/wk 20/60 MAINTENANCE 2/wk MAINTENANCE 1/wk 2/60 POLLEN CONTINUOUS 8/43 POLLEN PRESEASONAL 3/43 POLLEN COSEASONAL POLLEN PRECOSEASONAL 29/43 Lombardi et al, Allegy 2009

15 SLIT 31/60 (1 negative) 20/60 (1 negative) 7/60 (1 negative)
NO BUILD UP 7/60 MAINTENANCE DAILY 31/60 (1 negative) MAINTENANCE 3/wk 20/60 (1 negative) MAINTENANCE 2/wk 7/60 (1 negative) MAINTENANCE 1/wk 2/60 (1 negative) POLLEN CONTINUOUS 8/43 POLLEN PRESEASONAL 3/43 POLLEN COSEASONAL POLLEN PRECOSEASONAL 29/43 Lombardi et al, Allegy 2009

16 SLIT POLLEN CONTINUOUS 8/43 POLLEN PRESEASONAL 3/43 POLLEN COSEASONAL
NO BUILD UP 7/60 MAINTENANCE DAILY 31/60 MAINTENANCE 3/wk 20/60 MAINTENANCE 2/wk MAINTENANCE 1/wk 2/60 POLLEN CONTINUOUS 8/43 POLLEN PRESEASONAL 3/43 POLLEN COSEASONAL POLLEN PRECOSEASONAL 29/43 Lombardi et al, Allegy 2009

17 SLIT: Key-points Follow manufacturers’ instructions For seasonal allergies the pre-coseasonal regimen seems to be the best choice The build-up phase is not necessary and an be omitted The once daily administration is usually more convenient and easy to do.

18 ADHERENCE: The literature Curr Opin Allergy Clin Immunol 2009

19

20

21 1 visit/year 2 visit/year 3 visit/year

22

23 GRADING SIDE EFFECTS OF SUBLINGUAL IMMUNOTHERAPY SPEAKING THE SAME LANGUAGE
G.Passalacqua, CE Baena-Cagnani, J. Bousquet, GW Canonica, T. Casale, L.Cox, S.Durham, D. Larenas-Linnemann, RF Lockey, R. Pawankar, P.Potter, N. Rosario, D. Wallace, D. Ledford IN PREPARATION Symptom/sign (see Table 1) Grade 1 – Mild Grade 2 – Moderate Grade 3 - Severe Unknown severity Abdominal pain, Diarrhea Ear itching Pruritus/swelling of mouth, tongue or lip Nausea Throat irritation Uvular oedema Vomiting ● Not troublesome AND ● No symptomatic treatment required ● No discontinuation of SLIT because of local side effects ● Troublesome OR ● Requires symptomatic treatment ●No discontinuation of SLIT because of local side effects ·                     Grade 2 AND ·          SLIT discontinued because of local side effects The treatment is discontinued but there is no subjective and/or objective description of the severity from the patient/physician Each local adverse event can be early (<30 minutes) or delayed WAO, in preparation

24 Anaphylaxis with SLIT Author, year Sex (age) Allergen (producer) Phase
Onset Description Epinephrine De Groot, 2009 M (13) Grass (Grazax, ALK-Abellò) First dose 15 min Generalized urticaria, swelling of tongue NO F (27) 5 min Abdominal cramps, asthma, generalized itching, hypotension YES Blazowski, 2008 F (16) HDM (Staloral, Stallergenes) Maintenance overdose (60 drops) 10 min Hypotension-collapse, flushing, urticaria Eifan, 2008 F (11) dust mite + grass pollen mix (Stallergenes) Maintenance. 3 min Abdominal pain, chest pain, fever, nausea Not specified Dunski, 2006 F (31) Alternaria, cat, dog grass, ragweed, (Greer) 2nd day of updosing Angioedema, dizziness, dyspnea, generalized itching Antico, 2006 F (36) Latex End of rush buildup Asthma, generalized urticaria

25

26 THE SAFETY OF SUBLINGUAL IMMUNOTHERAPY WITH ONE OR MORE ALLERGENS IN CHILDREN
Fabio Agostinis, Marcello Cottini, Carlo Lombardi, Giorgio Walter Canonica, Giovanni Passalacqua ,Allergy 2008 in press SINGLE ALLERGEN n (%) MULTI ALLERGENS n (%) Grass 140 (82) Grass + pariet 6 (2) Parietaria 4 (3) Grass+ olive 18 (7) Birch 14 (9) Grass + birch +alder+hazelnut 220 (87) Ragweed Grass + ragweed 9 (4) Olive - Grass + mugwort Birch+hazelnut +alder TOTAL 172 (100) 253 (100) 415 children, 3-18 years, 272 male

27

28 SIT IN ASTHMA: PROBLEMS
The majority of the trials were not designed and sized for asthma as primary outcome Heterogeneity of study designs, duration, dose and evaluation parameters. Few studies had functional parameters evaluated

29 SLIT: Key-points Indications: the same as SCIT Assess the causal role of the allergen Safety: safer than SCIT (can be used cautiously also in children below 5 years) Follow manufacturers’ instructions Give the first dose under medical supervision Carefully instruct patients on the possible side effects and their management Check adherence (regular visits/phone calls) Optimal duration 3-4 years


Download ppt "Practical aspects Of SLIT"

Similar presentations


Ads by Google